Quantum Biopharma Ltd. Files March 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Mar 27, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, corporate-update
Related Tickers: HUGE
TL;DR
Quantum Biopharma (fka FSD Pharma) filed its March 6-K, confirming 20-F annual report filings.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on March 27, 2025. The company, incorporated in A6 with its principal executive offices in Toronto, Canada, is a foreign private issuer. This filing is for the month of March 2025 and indicates the company files annual reports under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's reporting status as a foreign private issuer, which can affect disclosure requirements and investor information.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- March 27, 2025 (date) — Filing date
- Toronto, Ontario (location) — Principal executive office location
- Form 20-F (document) — Annual report filing type
- Form 6-K (document) — Current filing type
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report for the month of March 2025 as a foreign private issuer and to indicate that the registrant files annual reports under cover of Form 20-F.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where are Quantum Biopharma Ltd.'s principal executive offices located?
Quantum Biopharma Ltd.'s principal executive offices are located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Does this filing contain new financial results or operational updates?
No, this Form 6-K filing is a routine report for the month of March 2025 and does not appear to contain new financial results or specific operational updates beyond confirming reporting status.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 27, 2025 regarding Quantum Biopharma Ltd. (QNTM).